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Abbreviations used in this paper:
 
 BrdU, bromodeoxyuridine; OPCs, oli-
godendrocyte precursor cells; TTX, tetrodotoxin.
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 are the numbers of different cell types matched
together during tissue development? The nervous
system has provided an excellent model system
for understanding this question as it contains two main
classes of cell types, neurons and glia. Presynaptic neurons
are believed to be precisely matched to their postsynaptic
target cells, either muscle cells or other neurons, by a
competition for limiting amounts of target-derived neu-
rotrophic factors (Purves, 1988). The number of some glial
cells that survive also appears to depend on a competition
for neuron-derived survival signals. In particular, the num-
ber of myelinating glial cells that survive appears to be
precisely matched during development to the number and
lengths of axons requiring myelination. Here we review re-
cent evidence that axons are the master regulators of oli-
godendrocyte development.
Oligodendrocytes are postmitotic cells that develop
 
from oligodendrocyte precursor cells (OPCs)
 
1
 
 that migrate
into developing white matter from their germinal zones.
The final number of oligodendrocytes in any part of the
CNS could, in principle, depend upon the number of
OPCs that migrate into it, the number of times the OPCs
divide before they differentiate, and the number of oligo-
dendrocytes and OPCs that undergo normal cell death in
the region. This issue has been intensively studied in the
rodent optic nerve, which contains two main glial cell
types, astrocytes and oligodendrocytes, in addition to the
axons of retinal ganglion cells.
Because the function of oligodendrocytes is to enhance
nerve conduction along axons, it would make logical sense
for axons to play an important part in controlling oligo-
dendrocyte development. Surprisingly, a role for axons
was not apparent initially as oligodendrocyte development
appears to occur normally in axon-free cultures. OPCs in
vitro and in vivo migrate, survive, and divide in response
to astrocyte-derived PDGF (Noble et al., 1988; Raff et al.,
1988; Richardson et al., 1988; Fruttiger et al., 1999). OPCs
also differentiate on schedule into oligodendrocytes in the
absence of axons (Abney et al., 1981; Raff et al., 1985). An
important role for axons was revealed, however, when it
was found that, after neonatal or postnatal optic nerves
are transected behind the eye, few oligodendrocytes de-
velop (Fulcrand and Privat, 1977; Wender et al., 1980; Pri-
vat et al., 1981; David et al., 1984; Valat et al., 1988; Barres
et al., 1993b). These observations revealed a powerful role
of axons in controlling oligodendrocyte development in
vivo. They also raised the questions of exactly how axons
control oligodendrocyte development: do they effect mi-
gration, proliferation, differentiation, or survival of OPCs
or oligodendrocytes, and by what molecular signals do
they act? We summarize here the recent studies that have
provided some answers to these questions.
 
Axons Stimulate OPC Proliferation and/or Survival but 
Do Not Regulate OPC Differentiation
 
To find out whether axons stimulate OPC proliferation,
several groups have taken advantage of the fact that astro-
cytes, oligodendrocytes, and OPCs each have a character-
istic antigenic phenotype (Raff et al., 1983a,b, 1984). This
allows the effects of transection on each cell type to be
specifically investigated. Neonatal transection, for exam-
ple, produces a large, more than a 10-fold decrease in the
percentage of astrocytes that incorporate bromodeoxyuri-
dine (BrdU; Burne and Raff, 1997), suggesting that axons
stimulate astrocyte proliferation, perhaps partly by releas-
ing sonic hedgehog (Wallace and Raff, 1999). In contrast,
transection does not significantly alter the percentage of
 
OPCs that incorporate BrdU (David et al., 1984; Ueda et al.,
1999). On the face of it, these findings suggest that axons
regulate astrocyte, but not OPC, proliferation.
The interpretation of these findings is not straightfor-
ward, however, because of an interesting difference in the
behavior of astrocytes and OPCs when they withdraw
from the cell cycle. Astrocytes do not alter their antigenic
phenotype when they stop dividing, whereas OPCs do.
When OPCs stop dividing, they quickly differentiate into
oligodendrocytes, thus losing their OPC-specific markers.
Thus, whereas the percentage of astrocytes that incorpo-
rate BrdU provides a meaningful index of their prolifera-
tion rate, the same may not be the case for OPCs. This
point is vividly illustrated by measuring BrdU incorpora-
tion by purified OPCs in culture in response to different
concentrations of their main mitogen PDGF (our unpub- 
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lished observations). Regardless of PDGF concentration,
the percentage of OPCs that incorporate BrdU does not
vary. What varies, however, is the number of OPCs and
oligodendrocytes. When PDGF concentration is high,
most of the cells are OPCs and few are oligodendrocytes.
When PDGF concentration is low, most of the cells be-
come oligodendrocytes. Therefore, the failure of axotomy
to influence the percentage of OPCs that incorporate
BrdU does not necessarily mean that axons do not regu-
late their division.
To reexamine the effects of axons on OPC proliferation,
Barres and Raff (1993) measured the total number of
OPCs and oligodendrocytes rather than the percentage
that incorporated BrdU. When developing optic nerves
are transected, the number of mitotic OPCs falls by 90%
in 4 d. This same percentage reduction was obtained re-
gardless of whether we measured the total number of mi-
totic OPCs per longitudinal section, the total number of
BrdU1 OPCs per entire optic nerve, or the number of all
OPCs per optic nerve. If the same experiment is per-
formed in mutant mice whose axons do not degenerate
after a transection (Brown et al., 1991), proliferation of
oligodendrocyte precursor cells also decreases by 90%,
raising the possibility that the proliferation depends on
electrical activity in axons (Barres and Raff, 1993). Consis-
tent with this possibility, intraocular injection of tetrodo-
toxin (TTX), which silences the electrical activity of retinal
ganglion cells and their axons, decreases the number of
OPCs by 80%. The effect of TTX is prevented by experi-
mentally increasing the concentration of PDGF in the de-
veloping optic nerve, suggesting that axonal electrical ac-
tivity normally controls the production and/or release of
the growth factors that are responsible for the prolifera-
tion and/or survival of OPCs (Barres and Raff, 1993).
Electrical activity could act indirectly by increasing glial
production of mitogens such as PDGF or directly by in-
creasing neuronal production or release of mitogens.
Whatever the mechanism, these data provided strong evi-
dence that axons control the rate of proliferation and/or
survival of developing OPCs.
In contrast, there is no evidence as yet that axons are re-
quired for OPC migration or differentiation into oligoden-
drocytes. It has recently been reported that axons are not
necessary for OPC migration (Ueda et al., 1999). Purified
OPCs in culture differentiate constitutively into oligoden-
drocytes in serum-free medium lacking specific inducing
signals (Raff et al., 1983b; Temple and Raff, 1986; Barres
et al., 1992). In the absence of axons, OPCs can differenti-
ate into oligodendrocytes in vivo (Fulcrand and Privat,
1977; David et al., 1984; Ueda et al., 1999). Axons in em-
bryonic and neonatal rats may instead inhibit the ability of
OPCs to differentiate into oligodendrocytes. OPCs ex-
press Notch1 receptors and activation of the Notch path-
way in purified OPCs in culture prevents their differen-
tiation into oligodendrocytes (Wang et al., 1998). As
neonatal axons express the Notch ligand Jagged1, which is
downregulated concurrently with the onset of rapid oligo-
dendrocyte generation, it is possible that axons help to
regulate the timing of myelination by preventing oligoden-
drocyte differentiation during the first neonatal week.
Similarly, developing Schwann cells express little of the
myelin protein P0 before myelination in vivo, yet in cul-
 
ture purified Schwann cells in the absence of axons ex-
press a higher level of P0 (Cheng and Mudge, 1996). Thus,
whereas axons are not required to stimulate differentia-
tion of OPCs into oligodendrocytes, they may inhibit OPC
differentiation before myelination.
 
Axons Promote Oligodendrocyte Survival
 
Oligodendrocytes require survival signals in vitro and dur-
ing normal development in vivo to avoid programmed cell
death (Barres et al., 1992, 1993b). At least 50% of the oli-
godendrocytes produced in the optic nerve normally die
within 2 to 3 d after they are generated (Barres et al., 1992;
Raff et al., 1993). Most of the oligodendrocytes that sur-
vive for 3 or more days appear to survive for the lifetime
of the organism. Experimentally increasing the levels of
PDGF, IGF-1, CNTF, or NT-3 in the developing optic
nerve greatly decreases the death and increases the num-
ber of oligodendrocytes that develop (Barres et al., 1992,
1993a,b, 1994). These findings indicate that all of these sig-
naling molecules are normally present in subsaturating
amounts in the developing nerve and suggest that nor-
mally occurring oligodendrocyte death may reflect a com-
petition for survival signals that are limited in amount or
availability. As PDGF, IGF-1, NT-3, and CNTF are all
produced by optic nerve astrocytes and all promote the
survival of oligodendrocyte lineage cells in vitro and in
vivo, it seems likely that astrocytes play a part in support-
ing the survival of this lineage in the nerve, at least during
development.
In addition, many studies have suggested that the sur-
vival of oligodendrocytes depends strongly on axons.
There is general agreement that when the optic nerves are
examined several weeks after a neonatal transection, very
few oligodendrocytes and OPCs are found (Fulcrand and
Privat, 1977; Privat et al., 1981; David et al., 1984; Valat
et al., 1988; Barres et al., 1993b). This could be explained
largely by the effects of axons in stimulating OPC division
and/or survival or there could be additional effects of ax-
ons in promoting oligodendrocyte survival. The conclusion
that axons promote oligodendrocyte survival has been
drawn by nearly every investigator who has examined op-
tic nerves after transection. For instance, using electron
microscopy, Fulcrand and Privat (1977) observed cells
with the characteristic ultrastructure of oligodendrocytes
undergoing degeneration after postnatal transection. EM
is not sufficient to identify degenerating oligodendrocytes
unambiguously, however; but using an antigenic identifi-
cation, David et al. (1984) also concluded that axons likely
promote oligodendrocyte survival because of the severe
loss of oligodendrocytes despite some continued OPC pro-
liferation after neonatal transection.
Oligodendrocytes in the rat optic nerve are normally
generated predominantly between P5 and P45. Therefore,
in order to determine whether axons help to promote oli-
godendrocyte survival, it is important to examine the ef-
fects of postnatal transection performed after P5. When P8
or P12 optic nerves are transected behind the eye so that
the axons degenerate, the oligodendrocytes die (Barres et al.,
1993b; Trapp et al., 1997). Within 3 d after transection, the
number of cell undergoing apoptosis increases by more
than fourfold, and many of the dying cells can be identified 
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as oligodendrocytes based on expression of characteristic
antigenic markers. P8 optic nerves have about 35,000 oli-
godendrocytes per nerve; when examined 10 d after a P8
transection on P18, the nerves contain only about 3,000
oligodendrocytes, compared with the 125,000 found in
control P18 nerves (Barres et al., 1993b). Thus not only are
few new oligodendrocytes generated after a P8 transec-
tion, but 
 
.
 
90% of the oligodendrocytes present at P8 die.
The death of oligodendrocytes after P8 transection is pre-
vented if the levels of IGF-1, CNTF (Barres et al., 1993b),
or neuregulins (NRG; P.-A. Fernandez, D. Tang, L.
Cheng, A. Mudge, and M. Raff, manuscript submitted for
publication) are experimentally elevated.
How do axons regulate oligodendrocyte survival? Oli-
godendrocytes do not die if the optic nerve is transected in
WLD mutant mice in which the axons do not degenerate
(Brown et al., 1991) and the ability of axons to promote
oligodendrocyte survival does not depend on electrical ac-
tivity in the axons (Barres et al., 1993b). Purified neurons,
but not neuron-conditioned culture medium, promote the
survival of purified oligodendrocytes in vitro (Barres et al.,
1993b). These findings suggest that the axon-derived sig-
nal is contact-mediated and not dependent on electrical
activity. Neuregulins have recently been proposed to be
such a signal (see below).
How does one reconcile the findings that both astrocyte-
derived and axon-derived signals seem to promote oligo-
dendrocyte survival? It is possible that signals from both
sources collaborate to promote the survival of oligoden-
drocytes; alternatively, newly formed oligodendrocytes
may depend on the astrocyte-derived signals while more
mature oligodendrocytes may lose their dependence on
astrocytes and come to depend solely on axons for their
survival.
Immature Schwann cells are also strongly dependent on
axons for a survival signal (Ciutat et al., 1996; Grinspan
et al., 1996; Syroid et al., 1996; Trachtenberg and Thomp-
son, 1996; Carroll et al., 1997; Nakao et al., 1997). Interest-
ingly, one week after PNS myelination, Schwann cells no
longer depend on axons for their survival (Grinspan et
al., 1996) and may instead depend on autocrine signals
(Cheng et al., 1998). The same is true for oligodendro-
cytes, many but not all of which survive transection in
adult optic nerves (Vaughn and Pease, 1970; Fulcrand and
Privat, 1977; McPhilemy et al., 1990; Ludwin, 1990). These
changes in survival requirements are reminiscent of the
changes that occur in a number of types of neurons, in-
cluding sensory DRG neurons and sympathetic neurons,
that initially depend on target-derived signals for survival
but lose this dependence in the adult (Acheson et al.,
1995).
 
A Model for How Axons Control
Oligodendrocyte Number
 
A tentative model for how a competition for axon-depen-
dent survival signals may help to match oligodendrocyte
and axon numbers during development has been proposed
(Barres et al., 1993b; Barres and Raff, 1994). Once an oli-
godendrocyte precursor cell stops dividing and begins to
differentiate into an oligodendrocyte, its specific require-
ments for survival signals change: it rapidly loses its PDGF
receptors, for example, so that PDGF can no longer pro-
mote its survival (Hart et al., 1989; McKinnon et al., 1990).
It now has only 2–3 d to contact a nonmyelinated region of
axon that provides new signals that are required for its
continued survival. A cell that fails to find an axon will kill
itself (Fig. 1). Forcing oligodendrocytes to compete for
axon-dependent survival signals that are limited in amount
or availability would help to ensure that the final number
of oligodendrocytes is precisely matched to the number
(and length) of axons requiring myelination. Importantly,
according to this model, newly formed premyelinating oli-
godendrocytes depend on astrocyte-derived signals for
their survival for about the first 2 d, whereas after 3 d the
oligodendrocytes are more mature and depend primarily
upon an axon-derived signal.
Much evidence supports such a model. The model ex-
plains why most developing oligodendrocytes that die do
so 2 to 3 d after their generation and why most developing
oligodendrocytes die after axotomy. It also explains why
there appears to be a perfect matching between oligoden-
drocytes in the optic nerve and the number and lengths of
axons (see Barres and Raff, 1994); in normal CNS white
matter, all mature oligodendrocytes that survive seem to
myelinate axons. Since the proposal of this model, several
of its predictions have been tested. One prediction is that
if the number of axons is experimentally increased, then
the number of oligodendrocytes that survive will increase
proportionally. This has been found to be the case (Burne
et al., 1996). Another prediction is that oligodendrocytes
that succeed in contacting axons will preferentially sur-
vive, while those that don’t will die. This has been tested
and found to be true (Trapp et al., 1997). A last prediction
is that if the number of oligodendrocytes generated is ex-
Figure 1. A model for how oligodendrocyte number is matched
to axonal surface area. Once an OPC stops dividing and differen-
tiates into an oligodendrocyte (left side of figure), it has 2–3 d to
contact an unmyelinated region of axon, which provides a new
signal that the cell requires for continued survival. Astrocyte-
derived signals, such as PDGF, can promote the survival of newly
formed oligodendrocytes for at least 2 d (middle of figure). But
as the newly formed oligodendrocytes undergo further matura-
tion (right side of figure), they lose responsiveness to these astro-
cyte-derived signals and require an axonal signal to survive.
Those that fail to contact an axon by 3 d after generation undergo
apoptosis. 
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perimentally increased, increased death should reduce
their numbers to normal. This has also been found to be
the case, as overexpression of PDGF in transgenic mice
initially leads to an enormous increase in oligodendrocyte
numbers in the embryonic mouse spinal cord. All of the
extra oligodendrocytes die, however, so that by a week or
so after birth the number of oligodendrocytes is normal, as
predicted by the model because the number of axons has
not changed (Calver et al., 1998).
In a recent paper, Bruce Trapp and his colleagues re-
ported that rat optic nerve oligodendrocytes develop in
the absence of viable retinal ganglion cell axons (Ueda et al.,
1999). To find out whether axons regulated oligodendro-
cyte development, they performed neonatal axotomy of
the optic nerve. 7 d later, at P7, they found no change in
the density of OPCs and a 50% decrease in the density of
oligodendrocytes in optic nerve sections. However, be-
cause transection produces marked atrophy of the cut op-
tic nerve, their data demonstrate a large decrease in the to-
tal number of OPCs and oligodendrocytes per axotomized
nerve. Because they observed a fourfold decrease in the
cross sectional area of the transected nerves, their OPC
and oligodendrocyte density measurements indicate a
fourfold reduction in the total number of OPCs and an
eightfold reduction in the number of oligodendrocytes, by
only one week after axotomy. The new findings of Ueda
et al. (1999) therefore reconfirm the powerful role of ax-
ons in promoting the development of the oligodendrocyte
lineage, although this is not the conclusion they draw. In
fact, the presence of some oligodendrocyte lineage cells af-
ter neonatal transection (David et al., 1984; Ueda et al.,
1999) is expected, as the early stages of the oligodendro-
cyte lineage (oligodendrocyte precursor cells and newly
formed oligodendrocytes) are supported by astrocyte-
derived signals such as PDGF.
Ueda et al. (1999) also addressed whether axons help to
promote oligodendrocyte survival. In these experiments
they transected P4 nerves rather than P0 nerves in order to
allow time for at least some oligodendrocytes to be gener-
ated, and then examined the nerves at P7. They found
no change in the density of surviving oligodendrocytes or
the percentage of oligodendrocytes undergoing apoptosis,
suggesting to them that axons do not control oligodendro-
cyte survival. Interpretation of these findings, however, is
limited by the fact that very few oligodendrocytes are nor-
mally found in the optic nerve at P4 (Miller et al., 1985;
Barres et al., 1992). Thus nearly all of the oligodendro-
cytes examined between P4 and P7 would be newly
formed oligodendrocytes, which do not yet depend on ax-
ons to survive (Barres et al., 1993b). (That a small percent-
age of these oligodendrocytes are mature enough to de-
pend on axons is suggested by the observation of Ueda
et al. [1999] that there is a substantial increase in oligoden-
drocyte death one day after axotomy.) Clearly, for the ef-
fects of axons on oligodendrocyte survival to be examined
meaningfully, axotomy must be performed at a later post-
natal age after a significant number of oligodendrocytes
have been generated, as was done previously (Fulcrand
and Privat, 1977; Privat et al., 1981; Barres et al., 1993b).
Nonetheless, Trapp and colleagues concluded that their
data “argue against axonal regulation of optic nerve oligo-
dendrogenesis.” In fact, whereas the new data of Trapp
 
and colleagues provides evidence that axons do not
strongly promote the survival of just born oligodendro-
cytes, their new studies do not address whether axons pro-
mote the survival of oligodendrocytes that are at least 2 to
3 d beyond their birthday or older, as suggested by the
studies of Barres et al. (1992, 1994; see below).
Ueda et al. (1999) suggest an alternative model for how
oligodendrocyte numbers are controlled. They propose a
density-dependent feedback mechanism where oligoden-
drocytes inhibit OPC expansion. Whereas such a mecha-
nism might normally help to control the density of OPCs
and newly formed oligodendrocytes in developing white
matter (Zhang and Miller, 1996) and might explain the rel-
atively unaltered densities of OPCs and newly formed oli-
godendrocytes observed after axotomy by Ueda et al.
(1999), it is not sufficient to explain how the final number
of mature oligodendrocytes is determined. Even when the
density of OPCs and newly formed oligodendrocytes is
greatly increased by overexpression of PDGF, the final
number of mature oligodendrocytes is unaltered (Calver
et al., 1998). Moreover OPC proliferation continues in
adult rodent optic nerves, but the number of mature oligo-
dendrocytes does not change.
 
Neuregulin Is a Strong Candidate for an Axon-derived 
Promoter of Myelinating Cell Development
 
During the past several years, neuregulins (NRGs) have
emerged as a likely candidate for an axonal signal that pro-
motes both Schwann cell and oligodendrocyte develop-
ment. NRGs are a large family of proteins related to epi-
dermal growth factor. They occur in multiple isoforms,
some membrane bound and some soluble, that are encoded
by at least four alternatively spliced genes. They were first
identified as potent mitogens for Schwann cells and astro-
cytes in culture and called glial growth factor (Raff et
al., 1978; Brockes et al., 1980; Goodearl et al., 1993; Mar-
chionni et al., 1993). In the developing CNS, NRGs are pre-
dominantly or entirely expressed by neurons, which target
them to their axons throughout the CNS and PNS. NRGs
promote the survival and proliferation of cells in the Schwann
cell lineage by activating erbB2/erbB3 heterodimeric recep-
tors (Morrissey et al., 1995; Grinspan et al., 1996; Minghetti
et al., 1996). The entire Schwann cell lineage fails to de-
velop in erbB3 deficient transgenic mice (Riethmacher et
al., 1997) and in NRG-deficient transgenic mice (Meyer
and Birchmeier, 1995). Although, in principle, this finding
might be explained by the ability of neuronally derived
NRG to instruct multipotential neural crest cells to become
Schwann cells (Shah et al., 1994), it is unlikely to be the en-
tire explanation since in erbB2-deficient mice Schwann cell
precursor cells develop within the DRG but fail to migrate
into the peripheral nerves (Morris et al., 1999). Thus the
lack of Schwann cell development in these transgenic mice
may be accounted for by the loss of functional axonal NRG
signaling. Axons have been shown to promote the survival
and proliferation of Schwann cell lineage cells in vitro and
in vivo; NRGs mediate these axonal effects in culture ex-
periments (Morrissey et al., 1995; Dong et al., 1995, 1999),
as well as after axotomy of developing peripheral nerves
(Grinspan et al., 1996; Minghetti et al., 1996; Trachtenberg
and Thompson, 1996; Nakao et al., 1997; Kopp et al., 1997). 
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Similarly, the development of the oligodendrocyte lin-
eage also depends on NRG signaling. In culture, NRG
promotes the survival of oligodendrocytes and the prolif-
eration of OPCs (Canoll et al., 1996; Raabe et al., 1997; Shi
et al., 1998; Fernandez, P.-A., D. Tang, L. Cheng, A.
Mudge, and M. Raff, manuscript submitted for publica-
tion). When spinal cords from wild-type mice are cultured
as explants, the oligodendrocyte lineage fails to develop if
NRGs are neutralized (Vartanian et al., 1999). Moreover,
the oligodendrocyte lineage does not develop in spinal
cord explants obtained from NRG-deficient transgenic
mice, but can be rescued by addition of recombinant NRG
to the culture medium (Vartanian et al., 1999). The source
of the spinal cord derived NRG that promotes OPC devel-
opment is probably either motor neurons or ventral ven-
tricular zone cells, both of which contain NRG immunore-
activity and are close to the site of OPC generation
(Vartanian et al., 1999). These results clearly demonstrate
the importance of NRG for either the differentiation or
proliferation of OPCs. Recent experiments also provide
strong support for the role of neuronally derived NRG in
promoting oligodendrocyte survival as well. Retinal gan-
glion cells make NRG, which is targeted to their axons
(Meyer and Birchmeier, 1994; Shi et al., 1998). The sur-
vival-promoting effect of DRG axons in vitro is strongly
inhibited if NRG is neutralized. In the developing optic
nerve, neutralization of NRG increases normal oligoden-
drocyte death, whereas delivery of exogenous NRG de-
creases it; moreover, the oligodendrocyte death induced
by nerve transection is almost completely abolished by de-
livery of exogenous NRG (Fernandez, P.-A., D. Tang, L.
Cheng, A. Mudge, and M.C. Raff, manuscript submitted
for publication). These results suggest that NRG is one of
the major signals used by RGC axons to promote oligo-
dendrocyte survival in the developing optic nerve.
In addition, other axonal signals are likely to participate.
A recent study has suggested that integrin signaling helps
to promote axon-mediated oligodendrocyte survival in
DRG-oligodendrocyte co-cultures (Frost et al., 1999). This
is interesting as in other tissues integrin signaling has been
found to promote survival by enhancing responsiveness to
trophic peptides (Ruoslahti and Reed, 1994; Giancotti and
Ruoslahti, 1999). Thus it will be of great interest in future
studies to explore whether NRG and integrin signaling are
synergistic in promoting oligodendrocyte survival.
In summary, axons powerfully control the development
of myelinating glial cells. Recent studies have revealed
that axons promote oligodendrocyte development by help-
ing to drive the proliferation of OPCs and by promoting
the survival of mature, myelinating oligodendrocytes. Ax-
onally derived NRG is a likely candidate signal that medi-
ates these effects. Together, these recent studies provide
strong support for a model in which the number of my-
elinating cells is matched during development to the ax-
onal surface area requiring myelination.
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